158 related articles for article (PubMed ID: 8141123)
1. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis).
Solomon A; Weiss DT; Murphy C
Am J Hematol; 1994 Feb; 45(2):171-6. PubMed ID: 8141123
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin heavy-chain-associated amyloidosis.
Eulitz M; Weiss DT; Solomon A
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
[TBL] [Abstract][Full Text] [Related]
3. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
4. Renal AH Amyloidosis Associated With a Truncated Immunoglobulin Heavy Chain Undetectable by Immunostaining.
Manabe S; Hatano M; Yazaki M; Nitta K; Nagata M
Am J Kidney Dis; 2015 Dec; 66(6):1095-100. PubMed ID: 26362695
[TBL] [Abstract][Full Text] [Related]
5. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
7. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
8. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
10. Light chain-associated amyloid deposits comprised of a novel kappa constant domain.
Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117
[TBL] [Abstract][Full Text] [Related]
11. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
[TBL] [Abstract][Full Text] [Related]
12. AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment.
Gono T; Yazaki M; Fushimi T; Suzuki T; Uehara T; Sano K; Kametani F; Ito N; Matsushita M; Nakamura S; Hoshii Y; Matsuda M; Ikeda S
Am J Kidney Dis; 2006 May; 47(5):908-14. PubMed ID: 16632032
[TBL] [Abstract][Full Text] [Related]
13. Primary localized orbital amyloidosis composed of the immunoglobulin gamma heavy chain CH3 domain.
Tan SY; Murdoch IE; Sullivan TJ; Wright JE; Truong O; Hsuan JJ; Hawkins PN; Pepys MB
Clin Sci (Lond); 1994 Nov; 87(5):487-91. PubMed ID: 7874834
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
[TBL] [Abstract][Full Text] [Related]
15. Induction in mice of human light-chain-associated amyloidosis.
Solomon A; Weiss DT; Pepys MB
Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization including immunoelectron microscopy.
Mai HL; Sheikh-Hamad D; Herrera GA; Gu X; Truong LD
Am J Surg Pathol; 2003 Apr; 27(4):541-5. PubMed ID: 12657941
[TBL] [Abstract][Full Text] [Related]
17. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
18. Formation of amyloid fibers by monomeric light chain variable domains.
Brumshtein B; Esswein SR; Landau M; Ryan CM; Whitelegge JP; Phillips ML; Cascio D; Sawaya MR; Eisenberg DS
J Biol Chem; 2014 Oct; 289(40):27513-25. PubMed ID: 25138218
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
20. Metachronous development of nonamyloidogenic [lambda] light chain deposition disease and IgG heavy chain amyloidosis in the same patient.
Copeland JN; Kouides PA; Grieff M; Nadasdy T
Am J Surg Pathol; 2003 Nov; 27(11):1477-82. PubMed ID: 14576484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
